Annual Shareholders Equity
$701.30 M
+$138.40 M+24.59%
31 December 2023
Summary:
Pacific Biosciences of California annual stockholders equity is currently $701.30 million, with the most recent change of +$138.40 million (+24.59%) on 31 December 2023. During the last 3 years, it has risen by +$365.81 million (+109.04%). PACB annual shareholders equity is now -11.34% below its all-time high of $790.99 million, reached on 31 December 2021.PACB Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$453.12 M
-$39.58 M-8.03%
30 September 2024
Summary:
Pacific Biosciences of California quarterly stockholders equity is currently $453.12 million, with the most recent change of -$39.58 million (-8.03%) on 30 September 2024. Over the past year, it has dropped by -$310.62 million (-40.67%). PACB quarterly shareholders equity is now -46.11% below its all-time high of $840.81 million, reached on 30 September 2021.PACB Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PACB Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.6% | -40.7% |
| 3 y3 years | +109.0% | -46.1% |
| 5 y5 years | +514.9% | +788.2% |
PACB Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -11.3% | +109.0% | -46.1% | at low |
| 5 y | 5 years | -11.3% | +1177.0% | -46.1% | +994.7% |
| alltime | all time | -11.3% | +495.9% | -46.1% | +265.8% |
Pacific Biosciences Of California Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $453.12 M(-8.0%) |
| June 2024 | - | $492.70 M(-24.1%) |
| Mar 2024 | - | $649.02 M(-7.5%) |
| Dec 2023 | $701.30 M(+24.6%) | $701.30 M(-8.2%) |
| Sept 2023 | - | $763.74 M(+19.0%) |
| June 2023 | - | $642.00 M(-7.2%) |
| Mar 2023 | - | $692.12 M(+23.0%) |
| Dec 2022 | $562.90 M(-28.8%) | $562.90 M(-10.2%) |
| Sept 2022 | - | $626.59 M(-8.1%) |
| June 2022 | - | $681.89 M(-7.2%) |
| Mar 2022 | - | $734.58 M(-7.1%) |
| Dec 2021 | $790.99 M(+135.8%) | $790.99 M(-5.9%) |
| Sept 2021 | - | $840.81 M(+225.6%) |
| June 2021 | - | $258.25 M(-8.0%) |
| Mar 2021 | - | $280.55 M(-16.4%) |
| Dec 2020 | $335.49 M(+510.9%) | $335.49 M(+159.1%) |
| Sept 2020 | - | $129.50 M(+212.9%) |
| June 2020 | - | $41.39 M(-31.5%) |
| Mar 2020 | - | $60.40 M(+10.0%) |
| Dec 2019 | $54.92 M(-51.9%) | $54.92 M(+7.7%) |
| Sept 2019 | - | $51.01 M(-32.7%) |
| June 2019 | - | $75.75 M(-20.1%) |
| Mar 2019 | - | $94.85 M(-16.8%) |
| Dec 2018 | $114.06 M(+32.5%) | $114.06 M(-13.5%) |
| Sept 2018 | - | $131.88 M(+54.3%) |
| June 2018 | - | $85.47 M(-16.8%) |
| Mar 2018 | - | $102.74 M(+19.3%) |
| Dec 2017 | $86.10 M | $86.10 M(-15.1%) |
| Sept 2017 | - | $101.41 M(-12.5%) |
| June 2017 | - | $115.86 M(+67.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $69.19 M(-18.3%) |
| Dec 2016 | $84.67 M(+15.1%) | $84.67 M(-14.2%) |
| Sept 2016 | - | $98.68 M(-8.7%) |
| June 2016 | - | $108.07 M(+21.7%) |
| Mar 2016 | - | $88.78 M(+20.7%) |
| Dec 2015 | $73.54 M(+33.8%) | $73.54 M(+77.8%) |
| Sept 2015 | - | $41.37 M(+22.3%) |
| June 2015 | - | $33.84 M(-16.4%) |
| Mar 2015 | - | $40.47 M(-26.3%) |
| Dec 2014 | $54.95 M(-20.6%) | $54.95 M(+3.6%) |
| Sept 2014 | - | $53.03 M(-10.1%) |
| June 2014 | - | $59.02 M(-21.9%) |
| Mar 2014 | - | $75.53 M(+9.2%) |
| Dec 2013 | $69.18 M(-36.8%) | $69.18 M(-17.2%) |
| Sept 2013 | - | $83.54 M(-16.8%) |
| June 2013 | - | $100.40 M(-6.2%) |
| Mar 2013 | - | $107.09 M(-2.1%) |
| Dec 2012 | $109.38 M(-42.9%) | $109.38 M(-14.9%) |
| Sept 2012 | - | $128.54 M(-13.3%) |
| June 2012 | - | $148.20 M(-11.7%) |
| Mar 2012 | - | $167.90 M(-12.3%) |
| Dec 2011 | $191.46 M(-31.6%) | $191.46 M(-9.1%) |
| Sept 2011 | - | $210.68 M(-9.7%) |
| June 2011 | - | $233.33 M(-6.2%) |
| Mar 2011 | - | $248.67 M(-11.1%) |
| Dec 2010 | $279.87 M(-258.0%) | $279.87 M(-202.4%) |
| Sept 2010 | - | -$273.30 M(-307.6%) |
| June 2010 | - | $131.67 M(-174.3%) |
| Dec 2009 | -$177.12 M(+89.7%) | -$177.12 M |
| Dec 2008 | -$93.39 M | - |
FAQ
- What is Pacific Biosciences of California annual stockholders equity?
- What is the all time high annual shareholders equity for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual shareholders equity year-on-year change?
- What is Pacific Biosciences of California quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly shareholders equity year-on-year change?
What is Pacific Biosciences of California annual stockholders equity?
The current annual shareholders equity of PACB is $701.30 M
What is the all time high annual shareholders equity for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual stockholders equity is $790.99 M
What is Pacific Biosciences of California annual shareholders equity year-on-year change?
Over the past year, PACB annual stockholders equity has changed by +$138.40 M (+24.59%)
What is Pacific Biosciences of California quarterly stockholders equity?
The current quarterly shareholders equity of PACB is $453.12 M
What is the all time high quarterly shareholders equity for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly stockholders equity is $840.81 M
What is Pacific Biosciences of California quarterly shareholders equity year-on-year change?
Over the past year, PACB quarterly stockholders equity has changed by -$310.62 M (-40.67%)